0001127602-18-010264.txt : 20180305 0001127602-18-010264.hdr.sgml : 20180305 20180305204231 ACCESSION NUMBER: 0001127602-18-010264 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180301 FILED AS OF DATE: 20180305 DATE AS OF CHANGE: 20180305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOORE NICHOLAS G CENTRAL INDEX KEY: 0001216923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 18668392 MAIL ADDRESS: STREET 1: 495 EAST JAVA DRIVE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-03-01 0000882095 GILEAD SCIENCES INC GILD 0001216923 MOORE NICHOLAS G 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 Common Stock 2018-03-01 4 M 0 178 0 A 12233 D Phantom Stock 0 2018-03-01 4 M 0 178 0 D Common Stock 178 27170 D Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash. An aggregate of 178.180639 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.180639 was paid out in cash in connection with the conversion into shares of common stock. The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. /s/ Marissa Song by Power of Attorney for Nicholas G. Moore 2018-03-05